mediQuo — Unstaged equity · R$8.4M

Algar, through its corporate venture arm Algar Venture Builder, invested R$8.4M in MediQuo Brasil for a minority stake. The investment could rise to R$12.6M. It turns a commercial partnership that began in 2022 into an equity stake. The money goes to technology development and B2B commercial expansion in Brazil. The press calls this a strategic minority investment in the Brazilian operation, with no venture stage given.